Genetic counseling in psychiatry

Harvard Review of Psychiatry

Volumn 14, Issue 2, 2006, Pages 109-121

  Finn, Christine T ^a,b,c   Smoller, Jordan W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LABORATORY FOR MOLECULAR MEDICINE   (United States)

^c WACC 812 ^*  (United States)

Author keywords

Genetic counseling; Psychiatric genetics; Recurrence risks

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1; SEROTONIN TRANSPORTER;

ALZHEIMER DISEASE; ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; DEPRESSION; DIAGNOSTIC VALUE; DIGEORGE SYNDROME; FAMILY HISTORY; GENE IDENTIFICATION; GENE MUTATION; GENETIC COUNSELING; GENETIC PROCEDURES; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUNTINGTON CHOREA; MANIA; MEDICAL RESEARCH; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATIENT EDUCATION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PSYCHOSIS; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA;

GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MENTAL DISORDERS; PSYCHIATRY; RECURRENCE; RISK ASSESSMENT;

EID: 33645760482     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1080/10673220600655723     Document Type: Review

References (99)

1. Moldin SO. Report of NIMH Genetics Workgroup: summary of research. Biol Psychiatry 1999;45:573-602.
2. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005;10:40-68; image 5.
3. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386-9.
4. Hattori E, Liu C, Badner JA, et al. Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet 2003;72:1131-40.
5. Fraser FC. Genetic counseling. Am J Hum Genet 1974;26:636-61.
6. Merikangas KR, Risch N. Will the genomics revolution revolutionize psychiatry? Am J Psychiatry 2003;160:625-35.
7. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159:1-50.
8. Quaid KA, Aschen SR, Smiley CL, Nurnberger JI. Perceived genetic risks for bipolar disorder in a patient population: an exploratory study. J Genet Couns 2001;10:41-51.
9. Trippitelli CL, Jamison KR, Folstein MF, Bartko JJ, DePaulo JR. Pilot study on patients' and spouses' attitudes toward potential genetic testing for bipolar disorder. Am J Psychiatry 1998;155:899-904.
10. Smith LB, Sapers B, Reus VI, Freimer NB. Attitudes towards bipolar disorder and predictive genetic testing among patients and providers. J Med Genet 1996;33:544-9.
11. Jones I, Scourfield J, McCandless F, Craddock N. Attitudes towards future testing for bipolar disorder susceptibility genes: a preliminary investigation. J Affect Disord 2002;71:189-93.
12. Milner KK, Collins EE, Connors GR, Petty EM. Attitudes of young adults to prenatal screening and genetic correction for human attributes and psychiatric conditions. Am J Med Genet 1998;76:111-9.
13. Milner KK, Han T, Petty EM. Support for the availability of prenatal testing for neurological and psychiatric conditions in the psychiatric community. Genet Test 1999;3:279-86.
14. Meiser B, Mitchell PB, McGirr H, Van Herten M, Schofield PR. Implications of genetic risk information in families with a high density of bipolar disorder: an exploratory study. Soc Sci Med 2005;60:109-18.
15. Palmour RM. Genetic counselling for affective disease. Psychiatr J Univ Ott 1989;14:323-7; discussion 349-51.
16. Tsuang MT. Genetic counseling for psychiatric patients and their families. Am J Psychiatry 1978;135:1465-75.
17. Faraone SV, Tsuang MT, Tsuang DW. Genetics of mental disorders: a guide for students, clinicians, and researchers. New York: Guilford, 1999.
18. Bassett AS, Chow EW 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 1999;46:882-91.
19. Cassidy SB, Morris CA. Behavioral phenotypes in genetic syndromes: genetic clues to human behavior. Adv Pediatr 2002;49:59-86.
20. Estrov Y, Scaglia F, Bodamer OA. Psychiatric symptoms of inherited metabolic disease. J Inherit Metab Dis 2000;23:2-6.
21. Golomb M. Psychiatric symptoms in metabolic and other genetic disorders: is our "organic" workup complete? Harv Rev Psychiatry 2002;10:242-8.
22. Hodgkinson KA, Murphy J, O'Neill S, Brzustowicz L, Bassett AS. Genetic counselling for schizophrenia in the era of molecular genetics. Can J Psychiatry 2001;46:123-30.
23. Holland AJ, Whittington JE, Butler J, Webb T, Boer H, Clarke D. Behavioural phenotypes associated with specific genetic disorders: evidence from a population-based study of people with Prader-Willi syndrome. Psychol Med 2003;33:141-53.
24. Moldavsky M, Lev D, Lerman-Sagie T. Behavioral phenotypes of genetic syndromes: a reference guide for psychiatrists. J Am Acad Child Adolesc Psychiatry 2001;40:749-61.
25. Lyon G, Adams RD, Kolodny EH. Neurology of hereditary metabolic diseases of children. New York: McGraw-Hill, Health Professions Division, 1996.
26. Neill J. Whatever became of the schizophrenogenic mother? Am J Psychother 1990;44:499-505.
27. Fromm-Reichmann F. Notes on the development of treatment of schizophrenics by psychoanalytic psychotherapy. Psychiatry 1948;11:263-273.
28. Austin JC, Honer WG. The potential impact of genetic counseling for mental illness. Clin Genet 2005;67:134-42.
29. Schulz PM, Schulz SC, Dibble E, Targum SD, van Kammen DP, Gershon ES. Patient and family attitudes about schizophrenia: implications for genetic counseling. Schizophr Bull 1982;8:504-13.
30. Targum SD, Dibble ED, Davenport YB, Gershon ES. The Family Attitudes Questionnaire. Patients' and spouses' views of bipolar illness. Arch Gen Psychiatry 1981;38:562-8.
31. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 2003;123:48-58.
32. Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005;352:2515-23.
33. Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996;276:293-9.
34. Cannon TD, Huttunen MO, Dahlstrom M, Larmo I, Rasanen P, Juriloo A. Antipsychotic drug treatment in the prodromal phase of schizophrenia. Am J Psychiatry 2002;159:1230-2.
35. McGlashan TH, Zipursky RB, Perkins D, et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res 2003;61:7-18.
36. Phillips LJ, Yung AR, Yuen HP, Pantelis C, McGorry PD. Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia. Am J Med Genet 2002;114:929-37.
37. Tsuang MT, Stone WS, Faraone SV. Understanding predisposition to schizophrenia: toward intervention and prevention. Can J Psychiatry 2002;47:518-26.
38. Roberts JS. Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives. Gerontologist 2000;40:43-52.
39. Peay H, McInerney J. A pilot study on psychiatric genetic counseling: counselor's needs. J Genet Couns 2002;11:485.
40. Finn CT, Wilcox MA, Korf BR, et al. Psychiatric genetics: a survey of psychiatrists'knowledge, opinions, and practice patterns. J Clin Psychiatry 2005;66:821-30.
41. Hofman KJ, Tambor ES, Chase GA, Geller G, Faden RR, Holtzman NA. Physicians' knowledge of genetics and genetic tests. Acad Med 1993;68:625-32.
42. Taylor MR. A survey of chairpersons of departments of medicine about the current and future roles of clinical genetics in internal medicine. Genet Med 2003;5:328-31.
43. Wilkins-Haug L, Hill LD, Power ML, Holzman GB, Schulkin J. Gynecologists' training, knowledge, and experiences in genetics: a survey. Obstet Gynecol 2000;95:421-4.
44. Firth HV, Lindenbaum RH. UK clinicians' knowledge of and attitudes to the prenatal diagnosis of single gene disorders. J Med Genet 1992;29:20-3.
45. Geller G, Tambor ES, Chase GA, Hofman KJ, Faden RR, Holtzman NA. Incorporation of genetics in primary care practice. Will physicians do the counseling and will they be directive? Arch Fam Med 1993;2:1119-25.
46. Marteau TM. Communicating genetic risk information. Br Med Bull 1999;55:414-28.
47. Carnevale A, Lisker R, Villa AR, Casanueva E, Alonso E. Counselling following diagnosis of a fetal abnormality: comparison of different clinical specialists in Mexico. Am J Med Genet 1997;69:23-8.
48. Mahowald MB, Verp MS, Anderson RR. Genetic counseling: clinical and ethical challenges. Annu Rev Genet 1998;32:547-59.
49. Clarke A. Is non-directive genetic counselling possible? Lancet 1991;338:998-1001.
50. Kessler S. Psychological aspects of genetic counseling. XI. Nondirectiveness revisited. Am J Med Genet 1997;72:164-71.
51. Bennett RL, Steinhaus KA, Uhrich SB, et al. Recommendations for standardized human pedigree nomenclature. Pedigree Standardization Task Force of the National Society of Genetic Counselors. Am J Hum Genet 1995;56:745-52.
52. Moldin SO. Psychiatric genetic counseling. In: Guze SB, ed. Washington University Adult Psychiatry. St. Louis, MO: Mosby, 1997:365-381.
53. Smoller JW, Finn, CT, White CA. The genetics of anxiety disorders: an overview. Psychiatr Ann 2000;30:745-53.
54. Tsuang MT, Stone WS, Faraone SV. Genes, environment and schizophrenia. Br J Psychiatry 2001;178:S18-24.
55. Tsuang M. Schizophrenia: genes and environment. Biol Psychiatry 2000;47:210-20.
56. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001;158:1568-78.
57. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000;157:1552-62.
58. Folstein SE, Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2001;2:943-55.
59. Harper PS. Practical genetic counseling. Oxford, Boston: Butterworth-Heinemann, 1998.
60. McGuffin P, Owen MJ, Gottesman II. Psychiatric genetics and genomics. Oxford, New York: Oxford University Press, 2002.
61. Andreasen NC, Rice J, Endicott J, Reich T, Coryell W. The family history approach to diagnosis. How useful is it? Arch Gen Psychiatry 1986;43:421-9.
62. Bolton P, Macdonald H, Pickles A, et al. A case-control family history study of autism. J Child Psychol Psychiatry 1994;35:877-900.
63. Landa R, Piven J, Wzorek MM, Gayle JO, Chase GA, Folstein SE. Social language use in parents of autistic individuals. Psychol Med 1992;22:245-54.
64. Weissman MM, Wickramaratne P, Merikangas KR, et al. Onset of major depression in early adulthood. Increased familial loading and specificity. Arch Gen Psychiatry 1984;41:1136-43.
65. Lord C, Schopler E, Revicki D. Sex differences in autism. J Autism Dev Disord 1982;12:317-30.
66. Smalley SL, Asarnow RF, Spence MA. Autism and genetics. A decade of research. Arch Gen Psychiatry 1988;45:953-61.
67. Weissman MM, Wickramaratne P, Nomura Y, et al. Families at high and low risk for depression: a 3-generation study. Arch Gen Psychiatry 2005;62:29-36.
68. Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ 2003;327:741-4.
69. Forrow L, Taylor WC, Arnold RM. Absolutely relative: how research results are summarized can affect treatment decisions. Am J Med 1992;92:121-4.
70. Guttmacher AE, Collins FS. Welcome to the genomic era. N Engl J Med 2003;349:996-8.
71. Khoury MJ. Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genet Med 2003;5:261-8.
72. Meiser B, Dunn S. Psychological impact of genetic testing for Huntington's disease: an update of the literature. J Neurol Neurosurg Psychiatry 2000;69:574-8.
73. Kessler S, Field T, Worth L, Mosbarger H. Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet 1987;26:259-70.
74. Evers-Kiebooms G, Decruyenaere M. Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals. Patient Educ Couns 1998;35:15-26.
75. McDonald-McGinn DM, LaRossa D, Goldmuntz E, et al. The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients. Genet Test 1997;1:99-108.
76. Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997;34:798-804.
77. Shprintzen RJ. Velo-cardio-facial syndrome: a distinctive behavioral phenotype. Ment Retard Dev Disabil Res Rev 2000;6:142-7.
78. Pulver AE, Nestadt G, Goldberg R, et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 1994;182:476-8.
79. Papolos DF, Faedda GL, Veit S, et al. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 1996;153:1541-7.
80. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999;56:940-5.
81. Bassett AS, Chow EW, AbdelMalik P, Gheorghiu M, Husted J, Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry 2003;160:1580-6.
82. Murphy KC, Owen MJ. Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia. Br J Psychiatry 2001;179:397-402.
83. Inoue K, Lupski JR. Genetics and genomics of behavioral and psychiatric disorders. Curr Opin Genet Dev 2003;13:303-9.
84. Finn CT, Stoler JM, Smoller JW. Genetics and genetic disorders. In: Cassem NH, Stern TA, Rosenbaum JR, Jellinek MS, eds. Massachusetts General Hospital handbook of general hospital psychiatry. St. Louis, MO: Mosby, 2003.
85. Kaufman J, Yang BZ, Douglas-Palumberi H, et al. Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A 2004;101:17316-21.
86. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005;62:529-35.
87. Eley TC, Sugden K, Corsico A, et al. Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 2004;9:908-15.
88. Bird TD, Sumi SM, Nemens EJ, et al. Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol 1989;25:12-25.
89. Bertram L, Tanzi RE. The current status of Alzheimer's disease genetics: what do we tell the patients? Pharmacol Res 2004;50:385-96.
90. Relkin NR, Kwon YJ, Tsai J, Gandy S. The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease. Ann N Y Acad Sci 1996;802:149-76.
91. Post SG, Whitehouse PJ, Binstock RH, et al. The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. JAMA 1997;277:832-6.
92. Roberts JS, Barber M, Brown TM, et al. Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genet Med 2004;6:197-203.
93. Humphries SE, Ridker PM, Talmud PJ. Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation? Arterioscler Thromb Vasc Biol 2004;24:628-36.
94. Evans JP, Skrzynia C, Burke W. The complexities of predictive genetic testing. BMJ 2001;322:1052-6.
95. Yang Q, Khoury MJ, Botto L, Friedman JM, Flanders WD. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 2003;72:636-49.
96. Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002;347:1916-23.
97. Harper PS. Insurance and genetic testing. Lancet 1993;341:224-7.
98. Cunningham GC. The genetics revolution. Ethical, legal, and insurance concerns. Postgrad Med 2000;108:193-6, 199-200, 202.
99. Annas GJ. The limits of state laws to protect genetic information. N Engl J Med 2001;345:385-8.